The Philippine Society of Nephrology (PSN) awarded Boehringer Ingelheim (Philippines), Inc. the prestigious Presidential Service Award during the Annual Convention Opening Ceremony on April 24 ...

Global pharmaceutical giant Boehringer Ingelheim has signed a new five-year ... Brands include Frontline, Jardiance and NexGard. The firm’s revenue last year was approximately $30.1 billion ...

Ingelheim, Germany, May 6, 2025 – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a ...

NEW YORK, May 05, 2025--(BUSINESS WIRE)--Datavant, the leading health data platform company, today announced an expanded collaboration with Boehringer Ingelheim to support the pharmaceutical ...

RIDGEFIELD, Conn., May 22, 2025 /PRNewswire/ --Boehringer Ingelheim will present the latest data in its robust oncology pipeline at the 2025 American Society of Clinical Oncology (ASCO ...

Ingelheim, Germany, May 6, 2025 – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential ...

Ingelheim, Germany, 22 May 2025 - Boehringer Ingelheim today announced that new clinical data from two early-stage trials targeting the signal regulatory protein α (SIRPα) innate immune checkpoint ...

This partnership aims to integrate Tempus’s extensive de-identified database and analytical platform with Boehringer Ingelheim’s oncology pipeline. The collaboration is set to harness ...

In the collaboration with ViVerita, Boehringer Ingelheim aims to change this and pave the way to novel treatments for people living with cancer. "The ViVerita platform uniquely combines ...